Jean‐Daniel Lalau

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4

Jean‐Daniel Lalau, Farshad Kajbaf, Youssef Bennis et al. · Diabetes Care · 2018 · 156 citations · Full text

Disappearance of Aluminic Bone Disease in a Long Term Asymptomatic Dialysis Population Restricting Al(OH)<sub>3</sub> Intake: Emergence of an Idiopathic Adynamic Bone Disease Not Related to Aluminum

P. Morinière, Martine Cohen‐Solal, S. Belbrik et al. · ˜The œNephron journals/Nephron journals · 1989 · 108 citations

Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor.

M Phlipponneau, M Nocaudie, Jacques Epelbaum et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 105 citations

Somatostatin Radioanalog Scintigraphy, Pathology, Adrenal Gland +17

Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination.

Jean‐Daniel Lalau, M Andréjak, P Morinière et al. · PubMed · 1989 · 96 citations

Lactic Acidosis, Hemodialysis, Metformin Elimination +14